{"AllianceGenome": "3791", "HGNC": "3791", "MIM": "136430", "_id": "2348", "_version": 1, "accession": {"genomic": ["AP000812.4", "CH471076.1", "CP068267.2", "MN088084.1", "MN088085.1", "MN088086.1", "MN088087.1", "NC_000011.10", "NC_060935.1", "NG_015863.1", "U20391.1"], "protein": ["AAA35822.1", "AAA35823.1", "AAA35824.1", "AAA74896.1", "AAB05827.1", "AAB31700.1", "AAB31702.1", "AAB39751.1", "AAB39752.1", "AAB81938.2", "AAH02947.1", "AAP35822.1", "AND76671.1", "BAD97247.1", "CAA44610.1", "CAG46816.1", "EAW74848.1", "EAW74849.1", "EAW74850.1", "EAW74851.1", "EAW74852.1", "NP_000793.1", "NP_057936.1", "NP_057937.1", "NP_057941.1", "P15328.3", "QGS70233.1", "QGS70234.1", "QGS70235.1", "QGS70236.1"], "rna": ["AF000381.2", "AH004606.2", "AK223527.1", "BC002947.2", "BT007158.1", "CA450368.1", "CR542019.1", "J05013.1", "KU257686.1", "M25317.1", "M28099.1", "M35069.1", "NM_000802.3", "NM_016724.3", "NM_016725.3", "NM_016729.3", "NM_016730.1", "U78793.1", "U78794.1", "X62753.1"], "translation": [{"protein": "AND76671.1", "rna": "KU257686.1"}, {"protein": "AAB39751.1", "rna": "U78793.1"}, {"protein": "AAB31702.1", "rna": "AH004606.2"}, {"protein": "NP_000793.1", "rna": "NM_000802.3"}, {"protein": "NP_057941.1", "rna": "NM_016729.3"}, {"protein": "NP_057936.1", "rna": "NM_016724.3"}, {"protein": "AAP35822.1", "rna": "BT007158.1"}, {"protein": "AAH02947.1", "rna": "BC002947.2"}, {"protein": "AAA35822.1", "rna": "M28099.1"}, {"protein": "CAG46816.1", "rna": "CR542019.1"}, {"protein": "AAB39752.1", "rna": "U78794.1"}, {"protein": "AAA35824.1", "rna": "M35069.1"}, {"protein": "BAD97247.1", "rna": "AK223527.1"}, {"protein": "NP_057937.1", "rna": "NM_016725.3"}, {"protein": "AAB31700.1", "rna": "AH004606.2"}, {"protein": "AAB81938.2", "rna": "AF000381.2"}, {"protein": "AAA35823.1", "rna": "J05013.1"}, {"protein": "AAA74896.1", "rna": "M25317.1"}, {"protein": "CAA44610.1", "rna": "X62753.1"}]}, "alias": ["FBP", "FOLR", "FRalpha", "NCFTD"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2017-10-20T16:00:00.000Z", "disease_label": "neurodegenerative syndrome due to cerebral folate transport deficiency", "gcep": "Intellectual Disability and Autism Gene Curation Expert Panel", "moi": "AR", "mondo": "MONDO:0013110", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_22c12588-dc55-4e90-827a-d7a6349e38a9-2017-10-20T160000.000Z", "sop": "SOP5"}}, "ensembl": {"gene": "ENSG00000110195", "protein": ["ENSP00000308137", "ENSP00000377281", "ENSP00000377284", "ENSP00000377286", "ENSP00000502440"], "transcript": ["ENST00000312293", "ENST00000393676", "ENST00000393679", "ENST00000393681", "ENST00000675784"], "translation": [{"protein": "ENSP00000308137", "rna": "ENST00000312293"}, {"protein": "ENSP00000377286", "rna": "ENST00000393681"}, {"protein": "ENSP00000502440", "rna": "ENST00000675784"}, {"protein": "ENSP00000377284", "rna": "ENST00000393679"}, {"protein": "ENSP00000377281", "rna": "ENST00000393676"}], "type_of_gene": "protein_coding"}, "entrezgene": "2348", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 10.41591578, "exp_mis": 85.5434378, "exp_syn": 34.399948, "lof_z": 1.66231330508753, "mis_z": 1.03353247244804, "mu_lof": 7.71347713039e-07, "mu_mis": 7.40207532896e-06, "mu_syn": 2.88816884616e-06, "n_lof": 5.0, "n_mis": 66.0, "n_syn": 33.0, "p_li": 0.00741067522640952, "p_null": 0.0686576295193553, "p_rec": 0.923931695254235, "syn_z": 0.147973208560142}, "bp": 774, "cds_end": 71907221, "cds_start": 71903217, "n_exons": 4, "nonpsych": {"exp_lof": 9.3448666, "exp_mis": 77.3425259, "exp_syn": 31.0527278, "lof_z": 1.71712661273918, "mis_z": 0.879932722256739, "mu_lof": 7.71347713039e-07, "mu_mis": 7.40207532896e-06, "mu_syn": 2.88816884616e-06, "n_lof": 4.0, "n_mis": 62.0, "n_syn": 29.0, "p_li": 0.0292817584979859, "p_null": 0.0561310392608173, "p_rec": 0.914587202241197, "syn_z": 0.231923854196646}, "transcript": "ENST00000393679.1"}, "exons": [{"cdsend": 72196177, "cdsstart": 72192173, "chr": "11", "position": [[72189914, 72189931], [72192165, 72192341], [72195270, 72195459], [72195611, 72195747], [72195896, 72196323]], "strand": 1, "transcript": "NM_000802", "txend": 72196323, "txstart": 72189914}, {"cdsend": 72196177, "cdsstart": 72192173, "chr": "11", "position": [[72189708, 72189759], [72190575, 72190641], [72192165, 72192341], [72195270, 72195459], [72195611, 72195747], [72195896, 72196299]], "strand": 1, "transcript": "NM_016724", "txend": 72196299, "txstart": 72189708}, {"cdsend": 72196177, "cdsstart": 72192173, "chr": "11", "position": [[72189708, 72189759], [72192165, 72192341], [72195270, 72195459], [72195611, 72195747], [72195896, 72196299]], "strand": 1, "transcript": "NM_016725", "txend": 72196299, "txstart": 72189708}, {"cdsend": 72196177, "cdsstart": 72192173, "chr": "11", "position": [[72192139, 72192341], [72195270, 72195459], [72195611, 72195747], [72195896, 72196299]], "strand": 1, "transcript": "NM_016729", "txend": 72196299, "txstart": 72192139}], "exons_hg19": [{"cdsend": 71907221, "cdsstart": 71903217, "chr": "11", "position": [[71900958, 71900975], [71903209, 71903385], [71906314, 71906503], [71906655, 71906791], [71906940, 71907367]], "strand": 1, "transcript": "NM_000802", "txend": 71907367, "txstart": 71900958}, {"cdsend": 71907221, "cdsstart": 71903217, "chr": "11", "position": [[71900752, 71900803], [71901619, 71901685], [71903209, 71903385], [71906314, 71906503], [71906655, 71906791], [71906940, 71907343]], "strand": 1, "transcript": "NM_016724", "txend": 71907343, "txstart": 71900752}, {"cdsend": 71907221, "cdsstart": 71903217, "chr": "11", "position": [[71900752, 71900803], [71903209, 71903385], [71906314, 71906503], [71906655, 71906791], [71906940, 71907343]], "strand": 1, "transcript": "NM_016725", "txend": 71907343, "txstart": 71900752}, {"cdsend": 71907221, "cdsstart": 71903217, "chr": "11", "position": [[71903183, 71903385], [71906314, 71906503], [71906655, 71906791], [71906940, 71907343]], "strand": 1, "transcript": "NM_016729", "txend": 71907343, "txstart": 71903183}], "generif": [{"pubmed": 11925593, "text": "findings suggest that up-regulation of FRalpha gene and calcyclin gene expressions induced by Allitridi may play an important role in human gastric cancer cell differentiation"}, {"pubmed": 12516786, "text": "The 27 kDa protein representing soluble folate binding protein exhibited a greater affinity for ligand binding than the 100 kDa protein which possesses a hydrophobic tail identical to the one that anchors the folate receptor to the cell membrane."}, {"pubmed": 12612090, "text": "Nuclear mRNA instability due to a new ORF element determines tissue specificity of FRalpha. FR-alpha has constitutive mRNA & protein synthesis during the cell cycle & slow protein turnover, ensuring a high steady-state level to override the instability."}, {"pubmed": 12839949, "text": "The possible anticancer agent, CB300838 has a low affinity for this carrier which makes it a possible antitumor agent."}, {"pubmed": 14972645, "text": "Mutations in the 5'-untranslated region and proximal promoter of the folate receptor-alpha (FR-alpha) gene could be a new factor contributing to gene-food interaction explaining part of the hyperhomocysteinemia panorama."}, {"pubmed": 14972645, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 15340044, "text": "Downrwegulated in an antifolate resistant leukemia cell line."}, {"pubmed": 15754024, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15754024, "text": "polymorphism may contribute to susceptibility to gastric cancer in at-risk Chinese"}, {"pubmed": 16128986, "text": "FBP secreted from epithelia of epididymis & vas deferens. A small fraction of FBP associated with prostasome-like vesicles which adhere to spermatozoa in epididymal duct. FBP may have bacteriostatic function depriving folate-requiring bacteria of folate."}, {"pubmed": 16453285, "text": "FRalpha might confer a growth advantage to the tumor by modulating folate uptake from serum or by generating regulatory signals."}, {"pubmed": 16475900, "text": "Novel mutations in the 5'-UTR of the FOLR1 gene were discovered in patients with elevated levels of homocysteine."}, {"pubmed": 17035141, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17473184, "text": "This study suggests that FR alpha plays a role in the uptake of 5-methyltetrahydrofolate when the concentration gradient is insufficient for reduced folate carrier -mediated transport."}, {"pubmed": 17487842, "text": "intensity of folate receptor staining was strongly correlated with breast cancer outcome"}, {"pubmed": 17554378, "text": "folate receptor type beta is induced in a bone marrow engraftment model of acute myelogenous leukemia"}, {"pubmed": 17912458, "text": "Eight novel rare FOLR1 mutations with a combined prevalence of approximately 1.3% in Whites as well as two common polymorphisms with 5% and 13%, respectively, have been demonstrated."}, {"pubmed": 17912458, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18181001, "text": "Higher levels of FOLR1 appear to be associated with better prognoses for patients with lung adenocarcinomas."}, {"pubmed": 18588513, "text": "FBP/FRalpha isoforms were demonstrated for the 1st time in human blood.These isoforms on erythrocyte membranes, in granulocytes & serum, only constituted an almost undetectable fraction of the functional FBP. The FBPalpha in neutrophils was cytoplasmic."}, {"pubmed": 18988749, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 19048631, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19074442, "text": "that PCFT plays a role in FRalpha-mediated endocytosis by serving as a route of export of folates from acidified endosomes"}, {"pubmed": 19093297, "text": "Observational study of gene-disease association, gene-gene interaction, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19159907, "text": "To determine the influence of the genotype involved in RFC1 on the response to methotrexate treatment in pediatric osteosarcomas. Altered expression of RFC1 is a feasible mechanism by which osteosarcoma cells become resistant to methotrexate."}, {"pubmed": 19161160, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19324355, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19336370, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19446551, "text": "FRalpha regulates pituitary tumor cell proliferation and mechanistically may involve the NOTCH pathway"}, {"pubmed": 19454358, "text": "folate receptor levels effectively differentiate ovarian carcinoma from other cancers affecting the serosal cavities"}, {"pubmed": 19493312, "text": "Results identify the presence of folate receptor alpha in normal and pathological melanocytes and demonstrated that methotrexate is preferentially transported through this receptor in melanoma cells."}, {"pubmed": 19493349, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19585555, "text": "There were no clear individual associations between methionine, vitamin B(6), or multivitamin use and ovarian cancer risk overall or by FRalpha tumor status."}, {"pubmed": 19617914, "text": "results demonstrate that ovarian cancer patients have elevated levels of functional intact FRalpha. These findings support the potential use of circulating FRalpha as a biomarker of early ovarian cancer"}, {"pubmed": 19732866, "text": "An inherited brain-specific folate transport defect that is caused by mutations in the folate receptor 1 (FOLR1) gene coding for folate receptor alpha, was identified."}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19952865, "text": "High maternal autoantibody levels and blocking of folate binding to FRalpha in maternal serum during pregnancy are not associated with an increased risk of oral clefts in the offspring in this population-based cohort."}, {"pubmed": 20036773, "text": "Using immunohistochemistry, FRalpha was localized to microvillous plasma membrane of syncytiotrophoblasts during first trimester and at term."}, {"pubmed": 20037791, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20379614, "text": "Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20424473, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20634891, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20683905, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20683905, "text": "The rare alleles of specific single nucleotide polymorphisms within the FOLR1, FOLR2, and FOLR3 genes were statistically significant for association with meningomyelocele."}, {"pubmed": 20817090, "text": "Since the placenta is rich in C/EBPalpha, the findings underscore the multiplicity of mechanisms by which the FRalpha gene is under the exquisite control of steroid hormones."}, {"pubmed": 20857335, "text": "Mutation screening in the FOLR1 gene is advisable in children with profound 5MTHF deficiency and decreased CSF/serum folate ratio."}, {"pubmed": 21215055, "text": "The expression of FOLR1 is closely related to the occurrence of nasopharyngeal carcinoma and Taxol resistance."}, {"pubmed": 21215165, "text": "FRalpha mRNA levels were significantly higher in ovarian carcinomas compared with that of the borderline tumors."}, {"pubmed": 21215723, "text": "Data show that the photocytotoxicity induced by folate-targeted liposomes was improved."}, {"pubmed": 21572402, "text": "FRalpha expression is present in a subset of resected hepatic colorectal cancer metastases, and this marker is independently associated with survival"}, {"pubmed": 21647742, "text": "FR-alpha was expressed in the majority of serous ovarian tumors, although >50% of cases showed only weak expression."}, {"pubmed": 21938430, "text": "An ancient double-mutated haplotype 1816delC-1841A in the FOLR1 gene, is demonstrated."}, {"pubmed": 22089756, "text": "FRalpha may play an important role in the development and progression of NFAs."}, {"pubmed": 22265591, "text": "alpha-FR can be a potential biomarker for the prediction of chemotherapeutic responses and clinical prognosis."}, {"pubmed": 22304562, "text": "PCR analysis had confirmed the existence of FR-alpha, SMVT, and B ((0, +)) in Y-79 and ARPE-19 cells."}, {"pubmed": 22586289, "text": "studies suggest that different clinical severities do not necessarily correlate with residual function of folate receptor alpha mutants."}, {"pubmed": 22729036, "text": "High folate receptor alpha is associated with adenocarcinoma in non-small-cell lung carcinoma and and EGFR [corrected] mutation."}, {"pubmed": 22984810, "text": "a large percentage of lung cancers, including squamous cell carcinomas in addition to adenocarcinomas, strongly express folate receptor alpha"}, {"pubmed": 23023342, "text": "Expression of FOLR1 is higher in pituitary adenomas of patients who are older than 50 years."}, {"pubmed": 23144806, "text": "Overexpression of folate receptor alpha was associated with ovarian tumor progression."}, {"pubmed": 23243496, "text": "The folate receptor alpha translocates to the nucleus, where it binds to cis-regulatory elements at promoter regions of Fgfr4 and Hes1, and regulates their expression."}, {"pubmed": 23332132, "text": "EpCAM, FR-alpha, and VEGF-A are the most promising molecules for use in targeted intraoperative fluorescence imaging of endometriotic lesions owing to their favorable expression patterns and biomarker characteristics"}, {"pubmed": 23357463, "text": "Studies indicate that folate receptor alpha (FOLR1), a folate transporter, is an attractive target for cancer therapy due to its high affinity for folate, restricted range of expression in normal tissue and differential over-expression in malignant tissue."}, {"pubmed": 23518909, "text": "The data presented further support the hypothesis that folate receptor-alpha expression in gynecologic tumors is due to the cell of origin normally expressing this receptor"}, {"pubmed": 23528302, "text": "FOLR1 was significantly elevated in the serum of ovarian cancer patients compared to serum of both healthy controls and patients with benign gynecological conditions."}, {"pubmed": 23851396, "text": "crystal structure of human FRalpha in complex with folic acid at 2.8 A resolution"}, {"pubmed": 24028341, "text": "74% of ER/PR-negative and 80% of triple-negative breast cancers expressed folate receptor alpha (FRA). The expression of FRA was significantly associated with a worse disease-free survival."}, {"pubmed": 24206618, "text": "The FRalpha gene was expressed in all parathyroid cells analyzed, and the FRbeta gene was expressed by most."}, {"pubmed": 24771263, "text": "We concluded that quantitation of CTCs through FRalpha ligand-PCR could be a promising method for noninvasive diagnosis of bladder TCC."}, {"pubmed": 24810481, "text": "the conditions associated with circulating FOLR1 protein in healthy individuals"}, {"pubmed": 24993594, "text": "Survival times are improved in non-small-cell lung cancer patients whose tumors show strong membranous folate receptor alpha expression."}, {"pubmed": 25081683, "text": "FRalpha down-regulation might be capable of suppressing cervical cancer cell proliferation and promoting apoptosis."}, {"pubmed": 25323390, "text": "Molecular dynamic simulation of the binding process of folic acid to folate receptor alpha"}, {"pubmed": 25564455, "text": "Studies indicate folate receptor (FR) as a prognostic biomarker for ovarian cancer."}, {"pubmed": 25697897, "text": "this is the first study to simultaneously evaluate both DNA methylation and protein expression of all three folate transporter genes, FOLR1, PCFT, and RFC1, in colorectal cancer."}, {"pubmed": 25816016, "text": "triple negative/basal tumors were significantly associated with increased expression of FOLR1 mRNA, compared to ER+ and HER2+ tumors."}, {"pubmed": 25904506, "text": "Findings suggest the clinical development of IMGN853 as a novel targeted therapy for patients with folate receptor alpha (FRalpha)-expressing tumors."}, {"pubmed": 25971554, "text": "we confirmed the similarities between epithelial ovarian cancer and fallopian tube, normal and adenocarcinoma using FOLR1, FOLR2, CD68 and CD11b markers"}, {"pubmed": 26014017, "text": "The overexpression of folate receptor alpha mRNA was associated with growth of pituitary adenomas."}, {"pubmed": 26149693, "text": "Folate receptor expression on murine and human adipose tissue macrophages"}, {"pubmed": 26191275, "text": "Suggest that FRalpha overexpression may play a role in the endometrioid endometrium carcinoma carcinogenesis and carcinoma progression from endometrial hyperplasia."}, {"pubmed": 26359629, "text": "Suggest RNA CAR T cell therapy for the treatment of common epithelial cancers expressing folate receptor-alpha."}, {"pubmed": 26599808, "text": "Folate receptor alpha protein was expressed in the majority of lung adenocarcinomas and a minority of lung squamous cell carcinomas. Folate receptor alpha protein expression correlated with histologic grade for lung adenocarcinomas, and the greatest difference was observed between grade 1 and grade 3."}, {"pubmed": 26606305, "text": "This new protocol opens an effective way through synthesis and design of novel fluorescent nano-conjugates for FR expression investigation in tumor cells via targeted imaging, showing great potential in drug delivery mechanism study and cancer therapy"}, {"pubmed": 26617855, "text": "Suppression of FOLR1 by RNA interference altered gene expression profile of taxol-resistant nasopharyngeal carcinoma cells. Apoptosis-related genes, gene alterations in viral carcinogenesis/MAPK pathways may be important for taxol resistance reversal."}, {"pubmed": 27014973, "text": "Folr1 is a favorable target for fluorescence-guided surgery as tumor specific agent EC17 produced a clear fluorescent signal in ovarian and breast cancer tissue."}, {"pubmed": 27064343, "text": "Low expression level of FOLR1 is associated with neuroendocrine lung tumors."}, {"pubmed": 27328938, "text": "The present study shows the efficacy of silencing HuR in lung cancer cells using folate-conjugated nanoparticle system that is directed towards folate receptor-alpha overexpressing cancer cells."}, {"pubmed": 27562465, "text": "mTORC1 or mTORC2 silencing markedly decreases the plasma membrane expression of FR-alpha and RFC transporter isoforms without affecting global protein expression"}, {"pubmed": 27576898, "text": "In this study, folate receptor alpha (FRa)-targeted nano-liposomes (FLP) were designed to enhance the anti-tumor effect by targeting delivery of exogenous PEDF gene to cervical cancer cells..These results clearly showed that FLP were desired carriers for PEDF gene and FLP/PEDF might represent a potential novel strategy for gene therapy of cervical cancer."}, {"pubmed": 27941566, "text": "Folate Receptor Alpha Expression in Platinum Resistant/Refractory Ovarian Carcinomas and Primary Endocervical Adenocarcinomas."}, {"pubmed": 28138029, "text": "our results demonstrate the substantial therapeutic potential of novel 6-substituted pyrrolo[2,3-d]pyrimidine antifolates with dual targeting of PCFT and FRalpha toward Epithelial ovarian cancer that express a range of FRalpha, along with PCFT, as well as cisplatin resistance"}, {"pubmed": 28244241, "text": "Several experimental studies in mice and human epidemiological and genetics studies have suggested that FOLR1 abnormalities are involved in a portion of human neural tube defects (NTD), although the solo defect of FOLR1 did not cause NTD. (Review)"}, {"pubmed": 28410844, "text": "High Folate Receptor Alpha Expression Is Associated With Increased Risk of Recurrence in Triple-negative Breast Cancer."}, {"pubmed": 28416738, "text": "FolR1 is a predictive candidate and a therapeutic target for medulloblastoma."}, {"pubmed": 28430580, "text": "Data show that higher folate receptor alpha (FRalpha) expression is predictive of a favorable prognosis in pancreatic ductal adenocarcinoma (PDAC) and FRalpha may represent a promising target for treatments."}, {"pubmed": 28782518, "text": "The Folate receptor alpha is associated with the progression of cervical cancer and regulates cervical cancer cells growth through phosphorylating ERK1/2, c-Fos, and c-Jun, which are key factors of the ERK signaling pathway."}, {"pubmed": 28948692, "text": "We identified eight novel variants in SLC19A1 and twelve novel variants in FOLR1, FOLR2, and FOLR3. Pathogenic variants include c.1265delG in SLC19A1 resulting in an early stop codon, four large insertion deletion variants in FOLR3, and a stop_gain variant in FOLR3"}, {"pubmed": 29110850, "text": "The expression of folate receptor 1 (FOLR1) was significantly higher and occurred with higher frequency in metastatic lymph node samples from patients with advanced lung cancer."}, {"pubmed": 29352248, "text": "This study demonstrated a new approach using a combination of EpCAM and FRalpha as CTC-capture targets to increase the sensitivity of CTC detection in NSCLC efficiently, specifically, and quickly."}, {"pubmed": 29433550, "text": "that FOLR1 is highly expressed in ovarian cancer but is reduced following multidrug resistance. FOLR1 may be a useful biomarker for ovarian cancer, and it may be useful as a therapeutic application to improve sensitivity to cisplatin treatment"}, {"pubmed": 29616859, "text": "Study report the expression of both FR-alpha and FR-beta on CD138 + plasma cells isolated from patients with multiple myeloma and the up-regulation of both FR-alpha and FR-beta expression after exposure to all-trans retinoic acid in two model myeloma cell lines."}, {"pubmed": 29926190, "text": "Along with CA19-9, FR-alpha expression was an independent prognostic factor for the overall survival of pancreatic cancer patients."}, {"pubmed": 30452231, "text": "Used two fluorescently labeled conjugates of methotrexate, differently linked at the terminal groups, to clarify the uptake mechanism by folate receptor-alpha. The results demonstrate the importance of methotrexate amino groups in the interaction with folate receptor-alpha."}, {"pubmed": 30761774, "text": "High serum FOLR1 levels are associated with ovarian cancer."}, {"pubmed": 31639310, "text": "An all-atom bilayer, including 35 different lipid types asymmetrically distributed among the two monolayers, is suggested as a model neoplastic cell membrane. One molecule of folate receptor alpha is anchored into its outer leaflet, and the behavior of the system is explored by atomistic molecular dynamics simulations."}, {"pubmed": 31816239, "text": "Polydopamine-PEG-Folic Acid Conjugate Film Engineered TiO2 Nanotube Arrays for Photoelectrochemical Sensing of Folate Binding Protein."}, {"pubmed": 31820349, "text": "Comparison of a Short Versus Long Stokes Shift Near-Infrared Dye During Intraoperative Molecular Imaging."}, {"pubmed": 31926453, "text": "Decreased placental folate transporter expression and activity in first and second trimester in obese mothers."}, {"pubmed": 32421366, "text": "A systematic review and meta-analysis of higher expression of folate receptor alpha (FOLR1) predicts poor cancer prognosis."}, {"pubmed": 32450493, "text": "Correlation between the expression of folate receptor alpha (FRalpha) and clinicopathological features in patients with lung adenocarcinoma."}, {"pubmed": 32820034, "text": "CIC de novo loss of function variants contribute to cerebral folate deficiency by downregulating FOLR1 expression."}, {"pubmed": 33561557, "text": "Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells."}, {"pubmed": 33677528, "text": "Quantitative proteomics identifies FOLR1 to drive sorafenib resistance via activating autophagy in hepatocellular carcinoma cells."}, {"pubmed": 33737637, "text": "Folate transporter dynamics and therapy with classic and tumor-targeted antifolates."}, {"pubmed": 34008900, "text": "Cerebral folate transporter deficiency syndrome in three siblings: Why genetic testing for developmental and epileptic encephalopathies should be performed early and include the FOLR1 gene."}, {"pubmed": 34093861, "text": "Site-specific glycoproteomic analysis revealing increased core-fucosylation on FOLR1 enhances folate uptake capacity of HCC cells to promote EMT."}, {"pubmed": 34185411, "text": "Folate receptor alpha increases chemotherapy resistance through stabilizing MDM2 in cooperation with PHB2 that is overcome by MORAb-202 in gastric cancer."}, {"pubmed": 35094917, "text": "Emerging roles for folate receptor FOLR1 in signaling and cancer."}, {"pubmed": 35545363, "text": "Association of periconceptional folate supplements and FOLR1 and FOLR2 gene polymorphisms with risk of congenital heart disease in offspring: A hospital-based case-control study.\", trans \"FOLR1FOLR2."}, {"pubmed": 36245230, "text": "High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancer."}, {"pubmed": 36396012, "text": "Elevated expression of receptors for EGF, PDGF, transferrin and folate within murine and human lupus nephritis kidneys."}, {"pubmed": 36402875, "text": "Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes."}, {"pubmed": 36426547, "text": "High Expression of Folate Receptor Alpha (FOLR1) is Associated With Aggressive Tumor Behavior, Poor Response to Chemoradiotherapy, and Worse Survival in Rectal Cancer."}, {"pubmed": 37506533, "text": "Folate receptor alpha is widely expressed and a potential therapeutic target in uterine and ovarian carcinosarcoma."}, {"pubmed": 37883728, "text": "Mutational analysis of FOLR1 and FOLR2 genes in children with Myelomeningocele."}, {"pubmed": 38057830, "text": "Cancer-associated fibroblasts induce sorafenib resistance of hepatocellular carcinoma cells through CXCL12/FOLR1."}], "genomic_pos": {"chr": "11", "end": 72196323, "ensemblgene": "ENSG00000110195", "start": 72189558, "strand": 1}, "genomic_pos_hg19": {"chr": "11", "end": 71907345, "start": 71900602, "strand": 1}, "go": {"BP": [{"evidence": "ISS", "gocategory": "BP", "id": "GO:0001947", "qualifier": "involved_in", "term": "heart looping"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0003147", "qualifier": "involved_in", "term": "neural crest cell migration involved in heart formation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0003253", "qualifier": "involved_in", "term": "cardiac neural crest cell migration involved in outflow tract morphogenesis"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006898", "pubmed": 9545095, "qualifier": "involved_in", "term": "receptor-mediated endocytosis"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0007155", "qualifier": "involved_in", "term": "cell adhesion"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0007342", "qualifier": "involved_in", "term": "fusion of sperm to egg plasma membrane involved in single fertilization"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0015884", "pubmed": 8033114, "qualifier": "involved_in", "term": "folic acid transport"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0017015", "qualifier": "involved_in", "term": "regulation of transforming growth factor beta receptor signaling pathway"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0031103", "qualifier": "involved_in", "term": "axon regeneration"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0035036", "qualifier": "involved_in", "term": "sperm-egg recognition"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0046655", "qualifier": "involved_in", "term": "folic acid metabolic process"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0060828", "qualifier": "involved_in", "term": "regulation of canonical Wnt signaling pathway"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0061626", "qualifier": "involved_in", "term": "pharyngeal arch artery morphogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0061713", "qualifier": "involved_in", "term": "anterior neural tube closure"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0071231", "pubmed": 14722620, "qualifier": "involved_in", "term": "cellular response to folic acid"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0000139", "qualifier": "located_in", "term": "Golgi membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005634", "pubmed": 23243496, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005768", "qualifier": "located_in", "term": "endosome"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005789", "qualifier": "located_in", "term": "endoplasmic reticulum membrane"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0005886", "pubmed": 1840502, "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0009897", "qualifier": "is_active_in", "term": "external side of plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0009897", "pubmed": [2527252, 8033114], "qualifier": "located_in", "term": "external side of plasma membrane"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0009986", "pubmed": 19581412, "qualifier": "located_in", "term": "cell surface"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0012507", "qualifier": "located_in", "term": "ER to Golgi transport vesicle membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0016020", "pubmed": 10633085, "qualifier": "located_in", "term": "membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0016323", "pubmed": 10787414, "qualifier": "located_in", "term": "basolateral plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0016324", "pubmed": 10787414, "qualifier": "located_in", "term": "apical plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0030133", "qualifier": "located_in", "term": "transport vesicle"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0030136", "qualifier": "located_in", "term": "clathrin-coated vesicle"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0031526", "qualifier": "located_in", "term": "brush border membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0033116", "qualifier": "located_in", "term": "endoplasmic reticulum-Golgi intermediate compartment membrane"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0070062", "pubmed": [19199708, 23533145], "qualifier": "located_in", "term": "extracellular exosome"}], "MF": [{"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 32296183, "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0005542", "pubmed": [2527252, 10787414, 14722620, 19116913, 23851396], "qualifier": "enables", "term": "folic acid binding"}, {"category": "MF", "evidence": "NAS", "id": "GO:0005542", "pubmed": 1840502, "qualifier": "enables", "term": "folic acid binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0038023", "qualifier": "enables", "term": "signaling receptor activity"}, {"category": "MF", "evidence": "IC", "id": "GO:0061714", "qualifier": "enables", "term": "folic acid receptor activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0061714", "pubmed": 8033114, "qualifier": "enables", "term": "folic acid receptor activity"}]}, "homologene": {"genes": [[7955, 100073336], [8364, 394697], [9031, 395638], [9544, 718388], [9598, 451401], [9606, 2348], [9615, 609612], [9913, 539750], [10090, 14275], [10116, 171049]], "id": 7322}, "interpro": [{"desc": "Folate receptor", "id": "IPR004269", "short_desc": "Folate_rcpt"}, {"desc": "Folate receptor-like", "id": "IPR018143", "short_desc": "Folate_rcpt-like"}], "ipi": "IPI00441498", "map_location": "11q13.4", "name": "folate receptor alpha", "other_names": ["FR-alpha", "KB cells FBP", "adult folate-binding protein", "folate binding protein", "folate receptor 1 (adult)", "folate receptor alpha", "folate receptor, adult", "ovarian tumor-associated antigen MOv18"], "pantherdb": {"HGNC": "3791", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "95568", "ortholog_type": "LDO", "panther_family": "PTHR10517", "taxid": 10090, "uniprot_kb": "P35846"}, {"RGD": "71032", "ortholog_type": "LDO", "panther_family": "PTHR10517", "taxid": 10116, "uniprot_kb": "G3V8M6"}, {"Ensembl": "ENSGALG00000017343", "ortholog_type": "LDO", "panther_family": "PTHR10517", "taxid": 9031, "uniprot_kb": "F1N9X0"}, {"ZFIN": "ZDB-GENE-070615-23", "ortholog_type": "LDO", "panther_family": "PTHR10517", "taxid": 7955, "uniprot_kb": "A0A0R4IXN7"}], "uniprot_kb": "P15328"}, "pathway": {"kegg": {"id": "hsa04144", "name": "Endocytosis - Homo sapiens (human)"}, "reactome": [{"id": "R-HSA-199977", "name": "ER to Golgi Anterograde Transport"}, {"id": "R-HSA-199991", "name": "Membrane Trafficking"}, {"id": "R-HSA-204005", "name": "COPII-mediated vesicle transport"}, {"id": "R-HSA-392499", "name": "Metabolism of proteins"}, {"id": "R-HSA-446203", "name": "Asparagine N-linked glycosylation"}, {"id": "R-HSA-5653656", "name": "Vesicle-mediated transport"}, {"id": "R-HSA-5694530", "name": "Cargo concentration in the ER"}, {"id": "R-HSA-597592", "name": "Post-translational protein modification"}, {"id": "R-HSA-6807878", "name": "COPI-mediated anterograde transport"}, {"id": "R-HSA-948021", "name": "Transport to the Golgi and subsequent modification"}], "wikipathways": [{"id": "WP176", "name": "Folate Metabolism"}, {"id": "WP4217", "name": "Ebola Virus Pathway on Host"}]}, "pdb": ["4KM6", "4KM7", "4KMX", "4LRH", "5IZQ"], "pfam": "PF03024", "pharmgkb": "PA28207", "pharos": {"target_id": 1268, "tdl": "Tclin"}, "pir": "A44904", "reagent": {"CM-LibrX-no-seq": [{"id": "GNF325385", "relationship": "is"}, {"id": "GNF325386", "relationship": "is"}, {"id": "GNF325387", "relationship": "is"}], "CondMedia_CM_LibrAB": {"id": "GNF292872", "relationship": "is"}, "GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF218231", "relationship": "is"}, {"id": "GNF249539", "relationship": "is"}, {"id": "GNF249540", "relationship": "is"}, {"id": "GNF249541", "relationship": "is"}, {"id": "GNF249542", "relationship": "is"}, {"id": "GNF272811", "relationship": "is"}, {"id": "GNF272812", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF082569", "relationship": "is"}, {"id": "GNF082570", "relationship": "is"}, {"id": "GNF082571", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF054502", "relationship": "is"}, {"id": "GNF059279", "relationship": "is"}, {"id": "GNF074649", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF070877", "relationship": "is"}, {"id": "GNF070878", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF005462", "relationship": "is"}, "GNF_mm+hs_RetroCDNA": {"id": "GNF285600", "relationship": "is"}, "MasterSecretomicsList": [{"id": "GNF330816", "relationship": "is"}, {"id": "GNF332014", "relationship": "is"}, {"id": "GNF334022", "relationship": "is"}], "NIBRI_hs-Secretome_pDEST": {"id": "GNF336235", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF106438", "relationship": "is"}, {"id": "GNF146084", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000011.10", "NC_060935.1", "NG_015863.1"], "protein": ["NP_000793.1", "NP_057936.1", "NP_057937.1", "NP_057941.1"], "rna": ["NM_000802.3", "NM_016724.3", "NM_016725.3", "NM_016729.3", "NM_016730.1"], "translation": [{"protein": "NP_057937.1", "rna": "NM_016725.3"}, {"protein": "NP_000793.1", "rna": "NM_000802.3"}, {"protein": "NP_057936.1", "rna": "NM_016724.3"}, {"protein": "NP_057941.1", "rna": "NM_016729.3"}]}, "reporter": {"HG-U133_Plus_2": "204437_s_at", "HG-U95Av2": ["39311_at", "534_s_at", "821_s_at"], "HTA-2_0": ["TC11000754.hg.1", "TC11002773.hg.1"], "HuEx-1_0": ["3339378", "3339406"], "HuGene-1_1": "7942332", "HuGene-2_1": "16728632"}, "summary": "The protein encoded by this gene is a member of the folate receptor family. Members of this gene family bind folic acid and its reduced derivatives, and transport 5-methyltetrahydrofolate into cells. This gene product is a secreted protein that either anchors to membranes via a glycosyl-phosphatidylinositol linkage or exists in a soluble form. Mutations in this gene have been associated with neurodegeneration due to cerebral folate transport deficiency. Due to the presence of two promoters, multiple transcription start sites, and alternative splicing, multiple transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Oct 2009].", "symbol": "FOLR1", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1414662"}, "unigene": "Hs.73769", "uniprot": {"Swiss-Prot": "P15328"}, "wikipedia": {"url_stub": "Folate receptor 1"}}